Theabrownin alleviates nonalcoholic fatty liver disease by inhibiting the intestinal farnesoid X receptor–ceramide axis
Article in Food Frontiers (April 2024)
The most recent citing publications are shown below. View all 37 publications that cite this research output on Dimensions.
Article in Food Frontiers (April 2024)
Article in Trends in Food Science & Technology (April 2024)
Article in Foods (February 2024)